Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$94.50 USD

94.50
426,967

-0.23 (-0.24%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Why Should You Add Universal Health (UHS) to Your Portfolio?

Backed by its strategic measures, solid segmental contributions and a strong solvency level, Universal Health (UHS) holds potential to reap benefits for investors.

Cooper Companies (COO) Q3 Earnings & Revenues Beat Estimates

Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.

Encompass Health (EHC) Opens Hospital, Boosts Florida Footprint

Encompass Health (EHC) opens an inpatient rehabilitation hospital in Pensacola, FL aimed at providing improved health outcomes across the state.

Patterson Companies (PDCO) Q1 Earnings & Revenues Top Estimates

Patterson Companies' (PDCO) fiscal first-quarter 2022 results benefit from strong segmental performance.

Veeva Systems (VEEV) Q2 Earnings Beat Estimates, '22 View Up

Veeva Systems' (VEEV) fiscal Q2 results reflect impressive performances by both its segments.

Catalent's (CTLT) Q4 Earnings Top Estimates, Margins Rise

Catalent's (CTLT) robust performance across the majority of its segments drives its fourth-quarter fiscal 2021 top line.

Sapna Bagaria headshot

Encompass Health's (EHC) Growth View Makes It a Good Buy

Ageing population, building of hospitals and other operational efforts poise Encompass Health (EHC) well for long-term growth, thus making it a good investment option.

EHC vs. AMED: Which Stock Should Value Investors Buy Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

New Strong Buy Stocks for August 27th

CTRN, EHC, HMC, PPC, and MNTX have been added to the Zacks Rank #1 (Strong Buy) List on August 27, 2021.

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

Phibro (PAHC) Q4 Earnings Match Estimates, Margins Down

Phibro (PAHC) sees revenue growth in fourth-quarter fiscal 2021 due to strength in all three segments.

Encompass Health (EHC) Down 4% Since Last Earnings Report: Can It Rebound?

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect improvement at Dental segment.

Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Up

Medtronic's (MDT) fiscal first-quarter results reflect a strong recovery from the impact of the COVID-19 pandemic on elective procedures that the company experienced in 2020.

Zacks.com featured highlights include: Encompass Health Corp, Perficient and Saia

Zacks.com featured highlights include: Encompass Health Corp, Perficient and Saia

Swayta Shah headshot

3 Stocks With Upgraded Broker Ratings to Buy Right Away

By following broker ratings upgrades, you can easily find profitable stocks. So, we choose Encompass Health (EHC), Perficient (PRFT) and Saia (SAIA) as these have witnessed ratings upgrade.

Alcon (ALC) Q2 Earnings Top Estimates, 2021 Guidance Up

Alcon (ALC) records the highest sales in the second quarter of 2021 since its spin-off.

Here's Why You Should Invest in Encompass Health (EHC) Now

Encompass Health (EHC) is riding on top-line growth, higher patient volumes, continuous facility expansions and reducing debt levels.

National Vision (EYE) Q2 Earnings Top Estimates, 2021 View Up

Strength in Americas Best and Eyeglass World brands drove National Vision's (EYE) revenues in the second quarter of 2021.

New Strong Buy Stocks for August 12th

EHC, HVT, VRTV, HAFC, and STRL have been added to the Zacks Rank #1 (Strong Buy) List on August 12, 2021.

Accuray (ARAY) Posts In-Line Q4 Earnings, Beats on Revenues

Accuray (ARAY) registers growth in Service and Product revenues during fiscal Q4.

Haemonetics (HAE) Q1 Earnings Top Estimates, Margins Improve

Ongoing recovery in businesses, especially Hospital, and the initial Plasma Persona rollouts drove Haemonetics (HAE) fiscal first-quarter revenues.

EHC vs. AMED: Which Stock Should Value Investors Buy Now?

EHC vs. AMED: Which Stock Is the Better Value Option?

Quest Diagnostics (DGX) Hits a 52-Week High: What's Driving It?

A faster-than-expected recovery in base business and stabilized demand for COVID-19 testing instill optimism in Quest Diagnostics (DGX).

Inari Medical (NARI) Q2 Earnings Lag, Revenues Top Estimates

Inari Medical's (NARI) second-quarter 2021 results benefit from significant revenue growth and gross margin expansion.